Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC - Caraballo Galva, Leidy D.; Jiang, Xiaotao; Hussein, Mohamed S.; Zhang, Huajun; Mao, Rui; Brody, Pierce; Peng, Yibing; He, Aiwu Ruth; Kehinde‐Ige, Mercy; Sadek, Ramses; Qiu, Xiangguo; Shi, Huidong; et al. (Hepatology (Baltimore, Md.), 2022)
Keywords: Affinity; Antigens; Antitumor activity; Apoptosis; Avidity; Blood cancer; Chimeric antigen receptors; Epitopes; Hematological diseases; Heparan sulfate proteoglycans; Hepatology; Lymphocytes T; Monoclonal antibodies; Solid tumors; Tumor cells; Tumor-infiltrating lymphocytes; Tumors; Xenografts